Cognition Therapeutics is a clinical-stage biopharmaceutical company developing small molecule therapeutics for age-related degenerative diseases of the CNS and retina. Its lead candidate, zervimesine (CT1812), is an orally delivered small molecule designed to protect neuronal synapses by preventing binding of amyloid-beta and alpha-synuclein oligomers. The company is advancing zervimesine in Alzheimer's disease, dementia with Lewy bodies, and previously in dry AMD, funded primarily by approximately $171 million in NIH/NIA grants.
Q2 FY2026 — expected 2026-09-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001104659-26-034880 | EDGAR | 88K words |
| 2025-03-20 | 2024-12-31 | 0001558370-25-003341 | EDGAR | 87K words |
| 2024-03-26 | 2023-12-31 | 0001558370-24-003949 | EDGAR | 89K words |
| 2023-03-23 | 2022-12-31 | 0001558370-23-004401 | EDGAR | — |
| 2022-03-30 | 2021-12-31 | 0001558370-22-004672 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-07 | 2026-06-30 | 0001104659-26-092362 | EDGAR | 21K words |
| 2025-11-06 | 2025-09-30 | 0001104659-25-107402 | EDGAR | 24K words |
| 2025-08-07 | 2025-06-30 | 0001558370-25-010771 | EDGAR | 23K words |
| 2025-05-07 | 2025-03-31 | 0001558370-25-006612 | EDGAR | 20K words |
| 2024-11-13 | 2024-09-30 | 0001558370-24-015436 | EDGAR | 22K words |
| 2024-08-08 | 2024-06-30 | 0001558370-24-011464 | EDGAR | 21K words |
| 2024-05-07 | 2024-03-31 | 0001558370-24-006911 | EDGAR | 19K words |
| 2023-11-02 | 2023-09-30 | 0001558370-23-017321 | EDGAR | 20K words |
| 2023-08-08 | 2023-06-30 | 0001558370-23-013741 | EDGAR | 20K words |
| 2023-05-04 | 2023-03-31 | 0001558370-23-008117 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001558370-22-017604 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001558370-22-012749 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001104659-26-092037 | EDGAR | 2K words |
| 2026-03-26 | 0001104659-26-034876 | EDGAR | 3K words |
| 2026-03-02 | 0001104659-26-021904 | EDGAR | 2K words |
| 2026-01-27 | 0001104659-26-006813 | EDGAR | 1K words |
| 2025-12-18 | 0001104659-25-122555 | EDGAR | 1K words |
| 2025-11-06 | 0001104659-25-107390 | EDGAR | 2K words |
| 2025-09-15 | 0001104659-25-089737 | EDGAR | 4K words |
| 2025-08-28 | 0001104659-25-084845 | EDGAR | 19K words |
| 2025-08-26 | 0001104659-25-083059 | EDGAR | 1K words |
| 2025-08-07 | 0001104659-25-075268 | EDGAR | 2K words |
105 total filings indexed. 78 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001455365 |
| Ticker | CGTX |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.cogrx.com |
| Listed | 2021-10-08 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CGTX (~200 tokens, structured JSON with cryptographic provenance)